Final results of a phase II biomarker-driven study of ruxolitinib in relapsed and refractory T-cell lymphoma Meeting Abstract
| Authors: | Moskowitz, A. J.; Ghione, P.; Jacobsen, E. D.; Ruan, J.; Schatz, J. H.; Noor, S.; Myskowski, P.; Hancock, H.; Davey, T.; Obadi, O.; Onwasigwe, C.; Ganesan, N.; Pomerantz, L.; Jarjies, C.; Kumar, P.; Sigler, A.; Geyer, M. B.; Noy, A.; Straus, D. J.; Hollmann, T.; Dogan, A.; Galasso, N.; Inghirami, G.; Weinstock, D. M.; Horwitz, S. M. |
| Abstract Title: | Final results of a phase II biomarker-driven study of ruxolitinib in relapsed and refractory T-cell lymphoma |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577164602042 |
| DOI: | 10.1182/blood-2019-125017 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4019 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
